These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11063348)

  • 1. Renal transplant patient compliance with free immunosuppressive medications.
    Chisholm MA; Vollenweider LJ; Mulloy LL; Jagadeesan M; Wynn JJ; Rogers HE; Wade WE; DiPiro JT
    Transplantation; 2000 Oct; 70(8):1240-4. PubMed ID: 11063348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy.
    Chisholm MA; Mulloy LL; DiPiro JT
    Clin Transplant; 2005 Feb; 19(1):77-82. PubMed ID: 15659138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.
    Chisholm MA; Mulloy LL; Jagadeesan M; DiPiro JT
    Clin Transplant; 2001 Oct; 15(5):330-6. PubMed ID: 11678959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncompliance with immunnosuppressive medications after renal transplantation.
    Ghods AJ; Nasrollahzadeh D
    Exp Clin Transplant; 2003 Jun; 1(1):39-47. PubMed ID: 15859906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
    Mayer AD; Dmitrewski J; Squifflet JP; Besse T; Grabensee B; Klein B; Eigler FW; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales JM; Andres A; Johnson RW; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe JL; Talbot D; Pohanka E
    Transplantation; 1997 Aug; 64(3):436-43. PubMed ID: 9275110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
    Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
    Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
    Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
    Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
    Liu JY; You RX; Guo M; Zeng L; Zhou P; Zhu L; Xu G; Li J; Liu D
    Am J Ther; 2016; 23(3):e810-24. PubMed ID: 25299636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
    Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study.
    Greenstein S; Siegal B
    Transplantation; 1998 Dec; 66(12):1718-26. PubMed ID: 9884266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K; Davidson BR; Burroughs AK
    Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients.
    Chisholm-Burns MA; Kwong WJ; Mulloy LL; Spivey CA
    Am J Health Syst Pharm; 2008 Jul; 65(13):1242-7. PubMed ID: 18574014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine: the principal immunosuppressant for renal transplantation.
    Keown PA; Primmett DR
    Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
    [No Abstract]   [Full Text] [Related]  

  • 20. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.